EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, covering 2018-11-09 to 2024-11-21. Get the full timeline:
Most recent: FDA Approved: EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)